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Abstract
Background and objective
Over recent decades, a progressive increase in the maternal age at childbirth has been
observed in developed countries, posing a health risk for both women and infants. The aim
of this study was to analyze the association between advanced maternal age (AMA) and
maternal and neonatal morbidity.
Material and methods
A cross-sectional study of 3,315 births was conducted in the north of Spain in 2014. We
compared childbirth between women aged 35 years or older, with a reference group of
women aged between 24 and 27 years. AMA was categorized based on ordinal ranking into
35–38 years, 39–42 years, and >42 years to estimate a dose-response pattern (the older
the age, the greater the risk). As an association measure, crude and adjusted Odds Ratios
(OR) were estimated by non-conditional logistic regression and 95% Confidence Intervals
(95%CI) were calculated.
Results
Repeated abortions were more common among women of AMA in comparison to pregnant
women aged 24–27 years (reference group): adjusted OR = 2.68; 95%CI (1.52–4.73). A
higher prevalence of gestational diabetes was also observed among women of AMA, reach-
ing statistical significance when restricted to first time mothers: adjusted OR = 8.55; 95%CI
(1.12–65.43). In addition, the possibility of an instrumental delivery was multiplied by 1.6
and the possibility of a cesarean by 1.5 among women of AMA, with these results reaching
statistical significance, and observing a dose-response pattern. Lastly, there were associa-
tions between preeclampsia, preterm birth (<37 weeks) and low birthweight, however with-
out reaching statistical significance.
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Conclusion
Our results support the association between AMA and suffering repeated abortions. Like-
wise, being of AMA was associated with a greater risk of suffering from gestational diabetes,
especially among primiparous women, as well as being associated with both instrumental
deliveries and cesareans among both primiparous and multiparous women.
Introduction
The average age at which women give birth has been steadily increasing over recent decades,
especially in developed countries. Several factors influence the rising age of motherhood.
Thus, the parallel increase in the age of emancipation, youth unemployment and the longer
periods of education, together with the penalization that women suffer in their professional
career when they have children, and the lack of measures to reconcile family and support
maternity are among the main reasons for this phenomenon. In addition, the changes in soci-
ety, lifestyle and work priorities, the improved accessibility and advancements in the field of
assisted reproduction methods, have also helped to normalize motherhood at progressively
older ages [1–3].
This increase in maternal age is a worldwide phenomenon. In Canada, there has been an
increase in the percentage of births from women aged between 35–39 years, ranging from
4.7% in 1982 to 14.1% in 2002 [4]. In the UK, a similar phenomenon has been observed: in
1992, 12% of women who gave birth were approximately 35 years old, compared to 20% in
2016 [5]. Likewise, in the USA, birth rates among women of advanced maternal age (AMA)
have increased 12% from 2007 to 2016 [3]. In 2016, the birth rate of women aged between 35–
39 years was 52.7 for every 1000 women; the highest rate reported since 1962 while, for women
aged between 40–44 years, a birth rate of 11.4 for every 1000 women was registered; the highest
since 1966 [6].
In Spain, the crude birth rate has decreased by 10.6 points from 1976 to 2017, and the aver-
age age of women at childbirth has increased from 28.5 years in 1976 to 32.1 in 2017. The aver-
age age of first-time mothers has also increased, from 25.25 in 1975 to 30.9 in 2017. In
Cantabria (Spain), the mean age of women at childbirth in 2017 was 32.5 [7].
This progressive increase in maternal age poses a considerable health risk for women.
Advanced maternal age is defined as childbearing in a woman over 35 years of age [2, 8–10].
Many studies have reported an association between AMA and a greater incidence of gesta-
tional diabetes [2, 5,11,12], gestational high blood pressure [5], an increase in cesarean sections
[10–14], induced births [11,12], instrumental deliveries [14] and abortions [1].
Regarding neonatal outcomes, AMA is related with an increase of preterm births [5,15],
intrauterine growth restriction (IUGR) [5], a greater incidence of intrauterine fetal death [5]
and a low birth weight [9,15].
An important aspect worth considering in women with AMA is the difference in maternal
and neonatal risk according to the woman’s parity. Thus, primiparous women with AMA are
considered to be at highest risk of complications [2,8]. Primiparous women with AMA have a
greater risk of pre-eclampsia [16], HELLP syndrome [16], instrumental birth [2,5]; urgent
cesarean [2,5], fetal growth retardation [16], low birthweight [2,8] and perinatal death [5,8,16].
The aim of this study was to analyze the association between AMA and maternal and neo-
natal morbidity at a regional public hospital located in Cantabria, Spain.
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Materials and methods
A cross sectional study was performed. The total number of births that took place at the Mar-
que´s de Valdecilla University Hospital (MVUH) from January 1 to December 31, 2014 was
registered (n = 3,315 births). Information concerning each birth was gathered based on the
register of births at the MVUH. Qlikview computer applications were used to compare or
complete the information in cases where the record did not appear in the register.
The variables gathered were: maternal age at the time of birth, gestational diabetes, high
blood pressure without preeclampsia, preeclampsia, cesarean sections, parity (primiparous or
multiparous), degree of perineal tear, previous abortion, fetal death (prior to delivery), birth
weight and gestational age. According to established definitions, AMA was defined as
women� 35 years at delivery [2, 8, 9, 10]. The reference group was restricted to women aged
between 24 and 27 years old [2]. This age range encompasses women at a lower risk of mater-
nal and neonatal morbidity [2, 4, 10–13, 17–20], excluding very young women (i.e. women
under the age of 24 years) which, as in the case of AMA, may also be considered a risk factor
for pregnancy and birth [3]. Additionally, AMA was subdivided into women of between 35–38
years, 39–42 years and>42 years. This is similarly based on published research studies which
highlight the greater maternal and neonatal risk among women of a more AMA [21,22].
Birth weight was categorized as low birth weight (less than 2500 grams) or fetal macrosomia
(more than 4000 grams). In addition, we created a variable for neonatal weight according to
gestational week and gender. We classified ‘small for gestational age’ using the<10th percentile
of a previously published population-based reference, and we classified ‘large for gestational
age’ using the >90th percentile of a previously published population-based reference [23–25].
The gestational age was categorized as late preterm (less than 37 weeks) and premature (less
than 34 weeks).
Statistical analysis
The data analysis incorporated an initial descriptive analysis. For the categorical and discrete
variables, we estimated proportions with their corresponding 95% confidence intervals. This
was according to the Wilson method, and used the chi-squared Pearson’s test for comparisons.
Alternatively, we used the Fisher’s exact test whereby more than 20% of the fields presented a
number of expected cases less than, or equal to, five. For the continuous variables, we esti-
mated the mean and the standard deviation or, in the case of asymmetric distributions, the
median and interquartile range. The Shapiro-Wilk test was used to determine the normality of
the distributions. Comparisons for continuous variables were performed using the Student’s t-
test or the Mann-Whitney U test when appropriate. As the association measure, crude and
adjusted odds ratios (OR) were estimated by non-conditional logistic regression computing a
95% confidence interval (95%CI). The following predefined confounding variables were
included in the models, when appropriate: parity (primiparous vs multiparous), immigrant
status (native vs immigrant)[26], history of previous cesarean sections (no vs yes), onset of
labor (spontaneous vs induced).
The alpha error was set at 0.05 and all the p values were bilateral. All statistical analyses
were performed using the SPSS v22.0 package by IBM and Stata 13.0.
Ethical considerations
The research protocol for this study was approved by the Clinical Research Ethics Committee
in Cantabria. The data were anonymized and treated confidentially according to the personal
data protection legislation in place.
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Results
In 10 of the 3315 total births under study, it was not possible to identify the maternal age at the
time of birth. Table 1 summarizes the general characteristics of the study population, including
information regarding maternal age (n = 3305 births). The mean maternal age of the sample
was 32.52 years [SD = 5.14 years]. Of the total number of births 36.8% (n = 1216) were women
of AMA (� 35 years). The group comprising women aged between 24 and 27 years repre-
sented 9.25% (n = 306) of the total sample. Up to 55.5% of deliveries (n = 1835) were in pri-
miparous women. Up to 6.5% of pregnant women (n = 215) had a background of repeated
abortions (more than one abortion). In 2.6% of births (n = 86), pregnant women developed
gestational diabetes while 1.8% (n = 61) of pregnant women developed preeclampsia. The
global prevalence of instrumental deliveries and cesareans was 35.2 and 22.6%, respectively.
A low birth weight and premature births occurring at less than 37 weeks were the only
adverse results that were more prevalent in the group of<24 years when compared to the
group selected as the reference category (24–27 years).
With the exception of the percentage of induced births, the percentage of severe tears (3rd
and 4th degree tears) and birth weight > 4000 kg (fetal macrosomia), the remaining adverse
effects studied were more prevalent in the group of AMA when compared to the group
selected as the reference category.
Table 2 displays the associations between maternal and neonatal morbidity and AMA.
Regarding the women’s medical background, repeated abortions were 2.20 times more fre-
quent in women of AMA; 95%CI (1.27–3.82). When adjusting by the immigrant status, this
association was further supported: adjusted OR (aOR) = 2.68; 95%CI (1.52–4.73), p<0.001.
Regarding maternal morbidity, AMA was associated with a greater prevalence of gestational
diabetes, OR adjusted by parity and immigration 2.70; 95%CI (0.93–7.79). This association
reached statistical significance based on the Chi-Squared test (p = 0.044). The risk of pre-
eclampsia was three times higher among women of AMA, although this association did not
reach statistical significance: aOR = 2.98; 95%CI (0.87–10.21).
Lastly, after adjusting for the predefined confounding variables, a statistically significant
increase was observed, both for the risk of instrumental delivery, as well as for cesarean sec-
tions: aOR for instrumental deliveries = 1.61; 95%CI (1.20–2.17) p<0.001; aOR for cesar-
ean = 1.58; 95%CI (1.14–2.19), p = 0.005.
When restricting the analysis to primiparous women only (Table 3), the strength of the
association between the risk of suffering gestational diabetes and AMA increased, with gesta-
tional diabetes being eight times more prevalent among primiparous women of AMA:
aOR = 8.55; 95CI% (1.12–65.43), p = 0.015.
The association between repeated abortions, in both crude and adjusted models, was
restricted to primiparous women: aOR = 2.87; 95CI% (1.26–6.53). This was also the case for
the association with preeclampsia, although without statistical significance: aOR = 2.81; 95 CI
% (0.81–9.72).
Likewise, the adjusted associations, both for instrumental deliveries, as well as for cesarean
sections, were maintained: aOR for instrumental deliveries = 1.63; 95%CI (1.17–2.28); aOR for
cesarean = 1.47; 95%CI (1.02–2.13).
When categorizing AMA based on ordinal ranking into 35–38 years, 39–42 years, and >42,
a dose-response pattern was observed in the history of repeated abortions, and the risk of
instrumental delivery and cesarean section (the older the age, the greater the OR) (Tables 4
and 5).
Concerning the study of the neonatal and fetal results (prematurity, low Apgar, non-nor-
mative birth weight and intrauterine fetal death), no statistically significant positive results
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Table 1. General characteristics of the population under study according to the maternal age at the time of birth.
<24 24–27 28–34 �35 Total
n = 201 % � n = 306 % � n = 1582 % � n = 1216 % � n = 3305 % � p
Nationality
Autochthonous 133 66.2 225 73.5 1373 86.8 1103 90.7 2834 85.7
Immigrant 68 33.8 81 26.5 209 13.2 113 9.3 471 14.3 < 0.001
Obstetric history
Multiparous women (>1)
no 155 77.1 204 66.7 961 60.7 515 42.4 1835 55.5
yes 46 22.9 102 33.3 621 39.3 701 57.6 1470 44.5 < 0.001
Repeated abortions
No abortion 152 75.6 219 71.6 1211 76.5 806 66.3 2388 72.3
1 abortion 43 21.4 72 23.5 301 19.0 286 23.5 702 21.2
> 1 abortion 6 3.0 15 4.9 70 4.4 124 10.2 215 6.5 < 0.001
Previous cesarean
no 197 98.0 286 93.5 1490 94.2 1066 87.7 3039 92.0
yes 4 2.0 20 6.5 92 5.8 150 12.3 266 8.0 < 0.001
Onset of labor
Spontaneous 142 70.6 190 62.1 986 62.3 781 64.2 2099 63.5
Induced 59 29.4 116 37.9 595 37.6 435 35.8 1205 36.5 0.119
Maternal morbidity
Gestational diabetes
no 200 99.5 302 98.7 1544 97.6 1173 96.5 3219 97.4
yes 1 0.5 4 1.3 38 2.4 43 3.5 86 2.6 0.019
HTN composite
no 197 98.0 296 96.7 1506 95.2 1167 96.0 3166 95.8
yes 4 2.0 10 3.3 76 4.8 49 4.0 139 4.2 0.202
HBP without preeclampsia
no 198 98.5 299 97.7 1523 96.3 1186 97.5 3206 97.0
yes 3 1.5 7 2.3 59 3.7 30 2.5 99 3.0 0.103
Preeclampsia
no 200 99.5 303 99.0 1550 98.0 1191 97.9 3244 98.2
yes 1 0.5 3 1.0 32 2.0 25 2.1 61 1.8 0.278
Instrumental birth
no 144 71.6 199 65.0 1039 65.7 760 62.5 2142 64.8
Yes 57 28.4 107 35.0 543 34.3 456 37.5 1163 35.2 0.058
Cesarean section
No 174 86.6 238 77.8 1248 78.9 898 73.8 2558 77.4
yes 27 13.4 68 22.2 334 21.1 318 26.2 747 22.6 < 0.001
Severe tear (3rd or 4th degree)
no 173 99.4 238 99.2 1230 99.7 887 99.8 2528 99.6
yes 1 0.6 2 0.8 4 0.3 2 0.2 9 0.4 0.522
Neonatal morbimortality
Gestational age <37 weeks
no 182 91.5 285 93.1 1470 93.0 1103 90.9 3040 92.2
yes 17 8.5 21 6.9 110 7.0 110 9.1 258 7.8 0.190
Gestational age <34 weeks
no 194 97.5 298 97.4 1547 97.9 1180 97.3 3219 97.6
yes 5 2.5 8 2.6 33 2.1 33 2.7 79 2.4 0.739
(Continued)
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were obtained, neither with a strength of association of>1.50, nor for the general sample
(Table 2), or when restricted to primiparous women (Table 3).
Lastly, women with AMA had a lower risk of live fetal macrosomia: OR = 0.54; 95%CI
(0.32–0.92), and statistical significance was lost after adjusting by immigrant status:
aOR = 0.61; 95%CI (0.35–1.07). When restricting to primiparous pregnant women, this pro-
tective association was maintained, although without achieving statistical significance.
Discussion
Our hypothesis was that AMA is associated with maternal and neonatal morbidity. This
hypothesis was confirmed as this study revealed that repeated abortions and gestational dia-
betes were more common among women of AMA. In addition, the possibility of an instru-
mental delivery or a cesarean was also increased. Lastly, we observed non-statistically
significant associations between AMA and preeclampsia, preterm birth (<37 weeks) and low
birthweight.
Our results show that a medical history of repeated abortions is up to 2.68 times more com-
mon among women with AMA. Furthermore, when performing an ordinal categorization of
AMA, a dose-response pattern was observed, with an increased significant linear tendency of
repeated abortions as the maternal age increased. This may be because one of the known
causes of repeated abortions is chromosomic alterations [27], with evidence of an increased
risk of chromosomic alterations with increasing age. Similarly, the results of the cross-sectional
study published by Koo YJ et al., in 2012 [17] displayed an OR of 2.7; 95%CI (1.6–4.4),
p<0.001 for chromosome alterations and AMA, which increased to 12.3; 95%CI (6.5–23.2,
p<0.001 in women with an AMA greater or equal to 40 years. Regarding the association
Table 1. (Continued)
<24 24–27 28–34 �35 Total
n = 201 % � n = 306 % � n = 1582 % � n = 1216 % � n = 3305 % � p
Apgar <7 at 5 min��
no 199 99.5 300 99.0 1559 99.0 1179 98.4 3237 98.8
yes 1 0.5 3 1.0 15 1.0 19 1.6 38 1.2 0.345
Apgar <4 at 5 min��
no 200 100.0 303 100.0 1570 99.7 1193 99.6 3266 99.7
yes 0 0 4 0.3 5 0.4 9 0.3 0.513
Birth weight��
normal birth weight 162 91.5 238 88.5 1298 89.0 992 91.2 2690 89.9
low birth weight 9 5.1 10 3.7 66 4.5 49 4.5 134 4.5
fetal macrosomia 6 3.4 21 7.8 94 6.4 47 4.3 168 5.6 0.131
normal for gestational age 152 85.9 226 84.0 1238 85.0 921 84.9 2537 84.9
small for gestational age 3 1.7 6 2.2 25 1.7 26 2.4 60 2.0
large for gestational age 22 12.4 37 13.8 193 13.3 138 12.7 390 13.1 0.927
Intrauterine fetal death
No 201 100.0 306 100.0 1579 99.8 1209 99.4 3295 99.7
Yes 0 0 3 0.2 7 0.6 10 0.3 0.157
� % valid without missing data
�� only live fetuses
HTN Hypertension
HBP High Blood Pressure
https://doi.org/10.1371/journal.pone.0225074.t001
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between AMA and a history of abortions, the cohort study by Khalil A et al., in 2013 [28], pres-
ents results that support those of our study with an OR of 1.36; 95%CI (1.15–1.62), p<0.001.
Our findings also support a greater prevalence of gestational diabetes in women of AMA.
This is especially the case in primiparous women, where the prevalence of maternal morbidity
is up to 8.55 times greater. The revised literature which relates gestational diabetes with AMA
[5,11,12] supports our findings. In a cross-sectional study focused on primiparous women
published in 2015 [2], an OR of 3.58; 95%CI (2.09–5.79), p = 0.0001 was reported. Further-
more, in the study by Heras B et al., published in 2011 [11], comparing women both older and
younger than 35 years, the authors reported an OR of 3.66; 95%CI (1.50–8.91). These results
are supported by a recently published cross-sectional study [18], both in the group of 35–39
years: OR 1.15; 95%CI (1.01–1.27) as well as in the group of>40 years: OR 2.41; 95%CI (2.13–
3.76). The causes of gestational diabetes continue to be a subject under research. One of the
theories is that, in a normal pregnancy, the stimulus of placental lactogen and prolactin pro-
duce a pancreatic hyperplasia of the B cells. At the same time, diabetogenic hormones, such as
the growth hormone, the hormone that liberates corticotropin, placental lactogen and proges-
terone, produce an increased insulin resistance. When this insulin resistance cannot be
Table 2. Associations between AMA and obstetric background, maternal and neonatal morbidity, and intrauterine fetal death.
AMA (> = 35 years) Reference group (24–27 years)
n = 1216 % n = 306 % p OR crude 95% CI aOR 95% CI
Obstetric background
Multiparity (>1) (aOR1) 701 57.65 102 33.33 < 0.001 2.72 2.09 3.54 3.00 2.28 3.94
Repeated abortions >1 (aOR1) 124 10.20 15 4.90 0.004 2.20 1.27 3.82 2.68 1.52 4.73
Maternal morbidity
Gestational diabetes (aOR2) 43 3.54 4 1.31 0.044 2.77 0.99 7.77 2.70 0.93 7.79
HTN composite (aOR2) 49 4.03 10 3.27 0.537 1.24 0.62 2.48 1.56 0.76 3.18
HBP without preeclampsia (aOR2) 30 2.47 7 2.29 0.855 1.08 0.47 2.48 1.24 0.52 2.93
Preeclampsia (aOR2) 25 2.06 3 0.98 0.211 2.12 0.64 7.07 2.98 0.87 10.21
Instrumental birth (aOR3) 456 37.50 107 34.97 0.412 1.12 0.86 1.45 1.61 1.20 2.17
Cesarean section (aOR3) 318 26.15 68 22.22 0.158 1.24 0.92 1.67 1.58 1.14 2.19
Severe tear (3rd or 4th degree) (aOR3) 2 0.16 2 0.65 0.159 0.27 0.04 1.92 0.21 0.03 1.64
Neonatal morbidity
Gestational age <37 weeks (aOR1) 110 9.05 21 6.86 0.219 1.35 0.83 2.20 1.28 0.78 2.10
Gestational age <34 weeks (aOR1) 33 2.71 8 2.61 0.918 1.04 0.48 2.28 1.08 0.48 2.40
Apgar <7 at 5 min� (aOR4) 19 1.59 3 0.99 0.441 1.61 0.47 5.48 1.66 0.47 5.81
Apgar <4 at 5 min� 5 0.41 0 0.260
Low birthweight� (aOR1) 49 4.03 10 3.27 1.18 0.59 2.36 1.07 0.53 2.18
Fetal macrosomia �(aOR1) 47 3.87 21 6.86 0.057 0.54 0.32 0.92 0.61 0.35 1.07
Small for gestational age (aOR1) 26 2.40 6 2.23 1.06 0.43 2.61 1.02 0.41 2.57
Large for gestational age (aOR1) 138 12.72 37 13.75 0.894 0.92 0.62 1.35 1.00 0.67 1.50
Intrauterine fetal death 7 0.58 0 0.183
�only live fetuses
HTN Hypertension
HBP High Blood Pressure
aOR1: adjusted OR for immigration.
aOR2: adjusted OR for immigration and maternal parity.
aOR3: adjusted OR for immigration, parity, previous cesarean section, and onset of labor (spontaneous or induced).
aOR4: adjusted OR for immigration, parity, previous cesarean section, onset of labor (spontaneous or induced), and instrumental birth (yes/no).
https://doi.org/10.1371/journal.pone.0225074.t002
Advanced maternal age and maternal and neonatal morbidity
PLOS ONE | https://doi.org/10.1371/journal.pone.0225074 November 26, 2019 7 / 13
overcome, despite the hyperplasia of B cells, gestational diabetes occurs [29]. The potential
influence of maternal age on the development of gestational diabetes continues to be a subject
of research and requires further clarification and study.
We found a three-fold greater risk of preeclampsia among women with AMA. This factor
was reflected both in the total sample and when restricted to primiparous women, although
the latter association did not reach statistical significance. One of the possible limitations of
Table 3. Associations between AMA and obstetric history, maternal and neonatal morbidity and intrauterine fetal death; after restricting to primiparous women.
AMA (> = 35 years) Reference group (24–27 years)
n = 515 % n = 204 % p OR crude 95% CI aOR 95% CI
Obstetric history
Repeated abortions >1 (aOR1) 40 7.77 8 3.92 0.063 2.06 0.95 4.49 2.87 1.26 6.53
Maternal morbidity
Gestational diabetes (aOR1) 20 3.88 1 0.49 0.015 8.20 1.09 61.52 8.55 1.12 65.43
HTN composite (aOR1) 33 6.32 8 3.92 0.208 1.65 0.75 3.64 1.64 0.73 3.69
HBP without preeclampsia (aOR1) 17 3.30 5 2.45 0.551 1.36 0.50 3.73 1.32 0.47 3.71
Preeclampsia (aOR1) 21 4.08 3 1.47 0.079 2.85 0.84 9.66 2.81 0.81 9.72
Instrumental birth (aOR2) 281 54.56 88 43.14 0.006 1.58 1.14 2.20 1.63 1.17 2.28
Cesarean section (aOR2) 176 34.17 55 26.96 0.062 1.41 0.98 2.01 1.47 1.02 2.13
Severe tear (3rd or 4th degree) (aOR2) 1 0.19 1 0.49 0.554 0.44 0.03 7.11 0.38 0.02 6.14
Neonatal morbidity
Gestational age <37 weeks (aOR1) 64 12.43 18 8.82 0.168 1.47 0.85 2.55 1.40 0.80 2.46
Gestational age <34 weeks (aOR1) 16 3.11 7 3.43 0.827 0.90 0.37 2.23 1.04 0.41 2.62
Apgar <7 at 5 min� (aOR3) 14 2.72 2 1.00 0.161 2.78 0.63 12.35 2.12 0.46 9.68
Apgar <4 at 5 min� 3 0.58 0 0.275
low birthweight� (aOR1) 27 5.26 7 3.43 1.48 0.63 3.46 1.28 0.54 3.02
fetal macrosomia�(aOR1) 12 2.34 11 5.39 0.066 0.42 0.18 0.97 0.46 0.19 1.10
small for gestational age (aOR1) 13 2.90 3 1.72 1.67 0.47 5.95 1.55 0.43 5.66
large for gestational age (aOR1) 42 9.35 19 10.92 0.611 0.85 0.48 1.51 0.90 0.49 1.62
Intrauterine fetal death 2 0.39 0 0.373
� only live fetuses
aOR1: adjusted OR for immigration.
aOR2: adjusted OR for immigration, previous cesarean and type of onset of labor (spontaneous or induced).
aOR3: adjusted OR for immigration, previous cesarean section, onset of labor (spontaneous or induced), and instrumental birth (yes/no).
https://doi.org/10.1371/journal.pone.0225074.t003
Table 4. Associations between AMA categorized in an ordinal array and repeated abortions, gestational diabetes and preeclampsia.
Repeated abortions Gestational Diabetes Preeclampsia
Age No (n) Yes (n) aOR1 95% CI No (n) Yes (n) aOR2 95% CI No (n) Yes (n) aOR2 95% CI
Reference group (24–27 years) 291 15 1 302 4 1 303 3 1
AMA (ordinal)
35–38 years 818 65 1.87 1.03 3.39 856 27 2.27 0.77 6.68 865 18 2.89 0.83 10.13
39–42 years 238 49 4.76 2.57 8.84 271 15 4.01 1.28 12.45 281 5 2.49 0.58 10.70
>42 37 10 6.45 2.66 15.66 46 1 1.56 0.17 14.43 45 2 6.12 0.97 38.64
p trend <0.001 0.036 0.093
aOR1: adjusted OR for immigration
aOR2: adjusted OR for immigration and parity.
https://doi.org/10.1371/journal.pone.0225074.t004
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this study is the lack of statistical power. Therefore, certain associations may not reach statisti-
cal significance, especially due to the low prevalence of these morbidities (only 1% in women
aged 24–27 years, according to our results). A meta-analysis of 22 articles conducted on a total
of 5,244,543 women, supports this association, reporting an OR of 1.2; 95%CI (1.1–1.3) [30].
In terms of instrumental deliveries, our results suggest an association with AMA, as the risk
of instrumental deliveries was up to 1.61 times greater among AMA pregnant women overall,
and with a clear dose-response pattern (the older the woman, the greater the risk), thus, preg-
nant women aged over 42 years old had a 2.81 times greater risk of instrumental delivery when
compared to pregnant women aged between 24–27 years. When restricting to primiparous
women, the same strength of association was obtained: adjusted OR = 1.63; IC95% (1.17–
2.28). In 2015, Schimmel MS et al., [2], also reported a similar result concerning primiparous
women: OR = 1.59; 95%CI (1.19–2.14).
Lastly, concerning maternal morbidity, our results suggest a greater risk of cesarean births
among women with an AMA with a clear dose-response pattern, with cesarean sections being
4.17 times more common in pregnant women over the age of 42 years. The results of a cross-
sectional study [2] were similar to those obtained in our study, when comparing the group
with AMA to the same group of reference aged 24–27 years, as used in our study, reporting an
OR of 2.46; 95%CI (1.65–3.677), p<0.001. When dividing the group with AMA into ordinal
subgroups by age, a dose-response pattern was also obtained. Some studies also reveal a rela-
tionship between AMA and an increase in the percentage of cesarean sections [10–14]. There
is considerable controversy regarding the causes behind suffering an increased risk of a cesar-
ean among women of AMA. In a systematic review performed where this association was stud-
ied, the most common explanation was an inefficiency of the aged myometrium. This would
be in addition to a decrease in the number of oxytocin receptors and could lead to a cesarean
section as effective uterine dynamics were not achieved for dilation and delivery [13].
The neonatal results for prematurity reveal mixed results for AMA, with studies that do not
support this association or which present statistically significant results [2, 11, 18, 19]. This is
concurrent with other studies, such as a paper by Koo YJ et al 2012 [17], obtaining significant
results for births <37 weeks of gestation: OR 1.4 95%CI (1.2–1.7) p<0.001 and preterm births
<32 weeks’ gestation: OR 1.9 95%CI (1.3–2.7) p<0.001. Thus, in a cross-sectional study pub-
lished in 2015 [20], a significant association was observed for women>41 years. Our results
for the 37-week cut-off reveal a prevalence of preterm births up to 1.5 times greater in women
of AMA, although this association did not achieve statistical significance, possibly due to the
lack of statistical power mentioned previously. Therefore, future primary studies or meta-anal-
yses should also study this association.
Table 5. Associations between AMA categorized in an ordinal manner and the risk of instrumental birth, cesarean section and premature birth (<37 weeks).
Instrumental birth Cesarean section Gestational age <37 weeks
Age No (n) Yes (n) aOR1 95% CI No (n) Yes (n) aOR1 95% CI No (n) Yes (n) aOR2 95% CI
Reference group (24–27 years) 199 107 1 238 68 1 285 21 1
AMA (ordinal)
35–38 years 575 308 1.43 1.05 1.94 679 204 1.33 0.94 1.86 796 84 1.36 0.82 2.25
39–42 years 160 126 2.09 1.44 3.04 192 94 2.11 1.42 3.16 262 24 1.19 0.64 2.19
>42 25 22 2.81 1.38 5.71 27 20 4.17 2.05 8.49 45 2 0.57 0.13 2.52
p trend <0.001 <0.001 0.921
aOR1: OR adjusted by immigration, parity, previous cesarean section and type of onset of labor (spontaneous or induced).
aOR2: OR adjusted by immigration.
https://doi.org/10.1371/journal.pone.0225074.t005
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Relating to the low Apgar score at five minutes, no cases registered a score below four in the
group of pregnant women aged between 24–27 years, therefore an odds ratio association was
not possible. The differences in percentages did not achieve statistical significance because of
the low prevalence. This result is in agreement with previous findings [2, 17, 18].
Regarding the low birth weight, we found a positive association (AMA as a risk factor).
However, the magnitude of this association was low and did not yield statistical significance.
This coincides with the results reported in an article by Heras B et al., published in 2011 [11].
When restricted to primiparous women, our positive association remained albeit without sta-
tistical significance. Schimmel [2] also reported a positive association in primiparous women
albeit without statistical significance: OR 1.65, 95%CI (0.98–2.77), p = 0.058.
According to our results, there was a lesser prevalence of fetal macrosomia with AMA,
with the association being, therefore, negative as a protective factor. These results must be
interpreted with caution as, curiously, among the 24–27 years age group, selected as the refer-
ence, the prevalence of fetal macrosomia was 7.8%, greater than in women under the age of
24 where the prevalence was 3.4%, and also, when compared to the group that was immedi-
ately older (28–34 years), where the prevalence was 6.4%, although this could be purely coin-
cidental. Upon comparing these findings with the international literature available, a former
cross-sectional study also found an opposite association whereby AMA was associated
with an increased risk of newborns large for gestational age: OR 1.64; 95%CI (1.51–1.79),
p<0.001 [2].
In terms of implications for clinical practice, our results support the available evidence
between AMA and maternal and neonatal morbidity. This should be reflected in a more indi-
vidualized and comprehensive gestational control of these women. Initially, the preconception
consultation should include a specific preconception risk assessment specifically focusing on
the risks related to AMA. During gestation, given the increased risk of gestational diabetes, an
early screening in the first trimester may be recommended, especially in primiparous women,
together with preventive and health education and promotion activities insisting on the impor-
tance of diet and physical exercise. In the case of pre-eclampsia, the sum of risk factors such as
AMA, personal history, or obesity should be considered. When several of these factors are
present in the same woman, this may require an early and more exhaustive screening, thus
emphasizing once again the importance of diet and physical exercise and including weight
control. Lastly, in relation to fetal monitoring, an increase in the number of ultrasound scans
to assess fetal growth may be advisable.
In retrospective studies such as the present study, where data is based on secondary infor-
mation (medical records), one of the main limitations may be the poor quality of the informa-
tion, which could lead to a possible information bias. To minimize such bias, prior to the onset
of the study, we selected the variables which tend to be stated more homogenously, systemati-
cally and objectively in the medical records. However, it is important to note a further limita-
tion, as it was not possible to identify certain variables homogeneously and systematically,
such as the weight or BMI of the pregnant women; their educational level; or the pregnancies
as a result of treatment with reproductive technologies. These variables could potentially be
associated with both AMA and maternal and neonatal morbidity acting as confounding vari-
ables. The fact that we were able to study all the births occurring during the study period
would minimize the possibility of a selection bias. The study population represents 90% of all
the births attended in the autonomous community of Cantabria (Northern Spain) within the
public health system (according to the official data of births for the year 2014) and 73% of the
births if we were to include the births attended in the private health sector [31]. This also sup-
ports the external validity of our results.
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Conclusion
Our results show an association between AMA and a history of repeated abortions. Regarding
maternal morbidity, AMA was associated with a greater risk of suffering from gestational dia-
betes, especially among primiparous pregnant women, as well as being associated with instru-
mental deliveries and cesareans. Although our results were not statistically significant, an
association between AMA and a greater risk of preeclampsia is suggested.
In terms of a greater risk of neonatal morbidity, our results suggest an association between
a low birth weight and preterm births < 37 weeks, although these associations did not reach
statistical significance.
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